Article Versions Notes

De Matteis S, Scarpi E, Granato AM, Vespasiani-Gentilucci U, La Barba G, Foschi FG, Bandini E, Ghetti M, Marisi G, Cravero P, et al. Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin. International Journal of Molecular Sciences. 2019; 20(6):1503. https://doi.org/10.3390/ijms20061503

De Matteis, Serena, Emanuela Scarpi, Anna Maria Granato, Umberto Vespasiani-Gentilucci, Giuliano La Barba, Francesco Giuseppe Foschi, Erika Bandini, Martina Ghetti, Giorgia Marisi, Paola Cravero, and et al. 2019. "Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin" International Journal of Molecular Sciences 20, no. 6: 1503. https://doi.org/10.3390/ijms20061503

De Matteis, S., Scarpi, E., Granato, A. M., Vespasiani-Gentilucci, U., La Barba, G., Foschi, F. G., Bandini, E., Ghetti, M., Marisi, G., Cravero, P., Gramantieri, L., Cucchetti, A., Ercolani, G., Santini, D., Frassineti, G. L., Faloppi, L., Scartozzi, M., Cascinu, S., & Casadei-Gardini, A. (2019). Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin. International Journal of Molecular Sciences, 20(6), 1503. https://doi.org/10.3390/ijms20061503